Search the Newsreel

5 Insightful Analyst Questions From Charles River Laboratories’s Q2 Earnings Call

5 Insightful Analyst Questions From Charles River Laboratories's Q2 Earnings Call Charles River Laboratories' second quarter results were shaped by recovering biopharmaceutical demand and the impact of portfolio streamlining. Management highlighted that the rebound was most evident in the Discovery and Safety Assessment (DSA) …

Ipca Laboratories shares fall over 2%; strong financial performance reported

Wheaton Precious Metals (WPM) Q2 2026 Earnings Call Transcript

Wheaton Precious Metals (WPM) reported record financial and operational results for Q2 2026, driven by higher commodity prices and increased sales volumes, including a $4.3 billion silver stream acquisition at Antamina. The company achieved $929 million in revenue and $543 million in net earnings, …

Neuland Lab Consolidated June 2026 Net Sales at Rs 641.58 crore, up 119.15% Y-o-Y

Plato Income Maximiser Keeps Monthly Dividend Flow as Portfolio Outperforms Benchmark

Brooks Laboratories reports consolidated net loss of Rs 1.79 crore in the June 2026 quarter

Truist Financial Initiates Kratos Defense & Security Solutions(KTOS.US) With Buy Rating, Announces Target Price $104

Truist Financial has initiated coverage on Kratos Defense & Security Solutions (KTOS.US) with a Buy rating. The financial firm also set a target price of $104 for the stock, indicating confidence in the company's future performance.

Horace Mann Educators’s Q2 Earnings Call: Our Top 5 Analyst Questions

Horace Mann Educators's Q2 Earnings Call: Our Top 5 Analyst Questions Horace Mann Educators' results for Q2 reflected steady execution, with the company meeting Wall Street's revenue expectations and posting non-GAAP profit meaningfully above consensus. Management pointed to disciplined underwriting in Property & Casualty …

Top Abbott Executive Makes Bold Move With Fresh Insider Stock Sale

An executive at Abbott Laboratories (ABT), Louis H. Morrone, recently sold 5,850 shares of company stock for $642,505. This insider transaction provides investors with additional data to consider regarding the company's current valuation. Abbott's stock performance and analyst ratings are influenced by its strong …

WHEATON PRECIOUS METALS AKTIE: AI-Analysen, Prognose & Kursziel

Could Danaher Corporation (DHR)’s Bioprocessing Recovery Give Bio-Rad Laboratories (BIO) Stock a Boost?

When biopharmaceutical suppliers report earnings, ripples move fast across the sector. On July 21, Danaher Corporation (NYSE:DHR) reported its Q2 2026 results. While the life sciences giant continues to lead in financial scale, its bioprocessing unit missed expectations, signaling continued softness in broader biopharma …

Group One Trading LLC (CATO) reports 5.0% beneficial stake in Cato Corp

Group One Trading LLC has reported a 5.0% beneficial ownership stake in Cato Corp's Class A common stock, totaling 1,000,368 shares as of June 30, 2026. This stake includes options to buy 1,005,400 shares, and Group One Trading LLC maintains sole voting and dispositive …

Birgit Girshick Sells 6,500 Shares of Charles River Laboratories International (NYSE:CRL) Stock

Birgit Girshick, CEO of Charles River Laboratories International (NYSE:CRL), sold 6,500 shares of the company's stock for approximately $1.82 million. This transaction, executed under a Rule 10b5-1 trading plan, reduced her ownership by 15.29%. The company recently reported strong quarterly EPS and revenue that …

Global Atomic Q2 EPS turns to $0.01 profit, sales drop 42%

Charles River Laboratories International (NYSE:CRL) EVP Sells $1,038,657.24 in Stock

Charles River Laboratories International's EVP, Shannon Parisotto, sold 3,714 shares of company stock for approximately $1.04 million, reducing her holdings by 43.59%. This transaction was conducted under a pre-arranged Rule 10b5-1 plan. The company recently reported adjusted earnings of $3.02 per share, exceeding estimates, …

Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors

Charles River Laboratories International Inc. (CRL) stock fell 1.09% to $281.27 on Thursday, despite a positive trading session for the broader market. This underperformance snapped a seven-day winning streak for the company's shares. The S&P 500 Index rose 0.65%, and the Dow Jones Industrial …

Dana Incorporated (DAN) outlines Eaton Mobility spin-off merger and adjusted EBITDA focus

Dana Incorporated has detailed its proposed business combination with Mobility (USA) Corporation, a wholly-owned subsidiary of Eaton Corporation plc. The transaction involves an exchange offer where SpinCo shares are issued to Eaton shareholders, followed by SpinCo merging with Dana. The company emphasizes the use …

Artisan Partners (STVN) discloses 2.6M Stevanato shares held for clients

Artisan Partners entities have reported a beneficial ownership of 2,601,598 ordinary shares in Stevanato Group S.p.A. This stake represents 5.2% of the class, based on 49,709,718 shares outstanding as of March 31, 2026. The shares are held on behalf of discretionary clients of Artisan …

Atmos Energy (ATO) Posts Solid Growth and Reaffirms Guidance

Atmos Energy (NYSE:ATO) posted year-to-date fiscal 2026 net income of $1.2 billion, or $7.33 per diluted share, a 14.5% increase over the prior-year period, according to the company's Q3 2026 earnings call held August 6. Management reaffirmed full-year earnings guidance of $8.40 to $8.50 …

Charles River Labs (CRL) CEO exercises 6,500 options and sells shares under 10b5-1 plan

Charles River Laboratories (CRL) CEO Birgit Girshick exercised stock options for 6,500 shares on August 11, 2026, at an exercise price of $179.66 per share. Simultaneously, she sold these 6,500 common shares at $279.90 per share. These transactions were conducted under a pre-arranged Rule …

Charles River (CRL) executive Parisotto exercises options, sells 3,714 shares under 10b5-1 plan

Shannon M. Parisotto, CEVP, Discovery & Safety Assessment at Charles River Laboratories International, exercised stock options for 3,714 shares at $179.66 per share and simultaneously sold the same number of shares at $279.66 per share. These transactions, executed on August 11, 2026, were conducted …

Kratos Stock Stumbles Into Q4 Earnings After Red-Hot Run: Can Contracts Offset Margin Fears?

Wheaton Precious Metals (TSE:WPM) Insider Sells 3,733 Shares of Stock

Nikola Tatarkin, an insider at Wheaton Precious Metals (TSE:WPM), sold 3,733 shares of the company's stock for approximately C$705,537, reducing his stake by over 10%. This transaction occurred as Wheaton Precious Metals traded down 2.0% to C$184.15, despite reporting strong quarterly revenue of C$1.32 …

Invesco reports 2.98M-share stake in Charles River Laboratories (CRL)

Invesco Ltd., a Bermuda-based parent holding company, has reported a significant passive ownership position in Charles River Laboratories International, Inc. (CRL) common stock. The firm beneficially owns 2,984,785 shares, representing 6.2% of the outstanding common stock, held by its investment advisory clients. Invesco maintains …

Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High - Here's Why

Silicon Labs Q2 FY 2026: IoT Recovery Builds Momentum for Series 3 Platform

Silicon Labs reported strong Q2 FY 2026 earnings, showing sequential improvements in revenue, gross margin, and profitability, indicating a recovery in the IoT semiconductor sector. The company's new 22nm Series 3 platform is central to its strategy of moving into more complex, compute-heavy, and …

Eaton Corp. PLC stock underperforms Thursday when compared to competitors

Eaton Corp. PLC (ETN) shares fell 1.44% on Thursday, closing at $453.33, despite a generally positive trading session for the broader market. The stock's decline broke a two-day winning streak, with the S&P 500 and Dow Jones Industrial Average both seeing gains. This performance …

Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice

Johnson Rice upgraded Core Laboratories (NYSE:CLB) from a "hold" to a "buy" rating, setting a $21.00 price target. This upgrade implies a significant upside, although the broader analyst consensus remains "Hold." The company recently reported better-than-expected EPS but missed revenue estimates, while its CEO …

Stevanato Group S.p.A. (STVN) Stock Forecasts

Morningstar has initiated coverage on Stevanato Group S.p.A. (STVN) with a narrow moat rating and a fair value estimate of USD 21.10. The shares are currently considered fairly valued at their current price of 21.52. Stevanato Group provides glass and polymer drug containment, drug …

Dr. Reddy’s Laboratories (RDY) CEO API & Services Deepak Sapra resigns effective November 12, 2026

Dr. Reddy’s Laboratories announced that Deepak Sapra, CEO of API & Services and a Senior Management Personnel, has resigned to pursue outside opportunities. His resignation is effective November 12, 2026, and he will remain with the company until then to ensure a smooth transition …

Silicon Labs: Medical Revenue Surges 78% To Record As IoT Design Wins Accelerate

Silicon Labs reported a record 78% year-over-year increase in Medical revenue for Q2, driven by accelerating IoT design wins and stronger demand across its portfolio. Total Q2 revenue rose 18% to $228 million, with significant growth in Industrial & Commercial and Home & Life …

Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research

Wolfe Research upgraded Abbott Laboratories (NYSE:ABT) to "outperform" from "peer perform," setting a $130 price target, which suggests a 17.2% upside. This upgrade comes after Abbott's recent quarterly results surpassed expectations, with EPS of $1.31 and revenue of $12.59 billion, an increase of 13% …

Dev Accelerator Posts Q1 FY27 Earnings Call Audio for Investor Access

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

Kratos Defense Could Be a Huge Winner in Autonomous Warfare

Kratos Defense (NASDAQ: KTOS) is positioning itself across autonomous aircraft, propulsion, and satellite software as the Pentagon pursues affordable military systems at scale. The opportunity could be enormous, but its future depends on converting proven technology into sustained production and revenue. Stock prices used …